The article, written at the University of Wrocław, focuses on the development of a liposomal formulation containing the naturally-derived bioactive compound baicalein (BAI) for potential anti-pancreatic cancer therapy. The BAI-encapsulated liposomal suspension demonstrated high cytotoxic activity against pancreatic cancer cell lines, even spheroids (PrimeSurface 96U MS-9096UZ), while showing limited toxicity towards normal cells, making it a promising candidate for further exploration as an anticancer treatment for pancreatic ductal adenocarcinoma.

Read the Full Article